首頁 › 食道癌 › 賓夕法尼亞州 › Pittsburgh
Pittsburgh, PA 的 食道癌 臨床試驗
15 項針對 食道癌 的研究正在 Pittsburgh（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
招募中1/2 期
- UPMC Hillman Cancer Center-UPMC ( Site 4904), Pittsburgh
Distance-Based Exercise to Preserve Function and Prevent Disability
招募中
- UPMC Hillman Cancer Center, Pittsburgh
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
招募中1 期
- University of Pittsburgh Medical Center, Pittsburgh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- Allegheny Health Network, Pittsburgh
SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
招募中1 期
- UPMC Hillman Cancer Center, Pittsburgh
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
招募中3 期
- Research Site, Pittsburgh
- Research Site, Pittsburgh
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
招募中1/2 期
- UPMC Hillman Cancer Center-UPMC ( Site 8904), Pittsburgh
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
招募中1/2 期
- UPMC Hillman Cancer Center-UPMC ( Site 6904), Pittsburgh
Lead-212 PSV359 Therapy for Patients With Solid Tumors
招募中1/2 期
- University of Pittsburgh Medical Center, Pittsburgh
Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)
招募中
- UPMC Hillman Cancer Center, Pittsburgh
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
招募中2 期
- UPMC Hillman Cancer Center, Pittsburgh
Esophageal Cancer Risk Registry
招募中觀察性研究
- Department of Cardiothoracic Surgery, Pittsburgh
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
招募中觀察性研究
- University of Pittsburgh Medical Center - Department of Cardiothoracic Surgery, Pittsburgh
- UPMC - Hillman Cancer Center, Pittsburgh
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
招募中觀察性研究
- Allegheny Health Network, Pittsburgh
Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors
招募中1 期
- AHN West Penn Hospital, Pittsburgh
其他城市的 食道癌 試驗
- Houston, TX36 項研究
- Boston, MA23 項研究
- New York City, NY22 項研究
- Nashville, TN19 項研究
- St. Louis, MO17 項研究
- Los Angeles, CA15 項研究
- Baldwin Park, CA14 項研究
- Grand Rapids, MI14 項研究
- Philadelphia, PA13 項研究
- San Antonio, TX12 項研究
- Dallas, TX11 項研究
- Chicago, IL11 項研究
Pittsburgh 的其他研究
- 非小細胞肺癌48 項研究
- 癌症（所有類型）41 項研究
- 乳癌39 項研究
- 大腸直腸癌32 項研究
- 轉移性癌症31 項研究
- 黑色素瘤31 項研究
- 卵巢癌30 項研究
- 子宮內膜癌23 項研究
- 前列腺癌23 項研究
- 肺癌23 項研究
- 頭頸部鱗狀細胞癌22 項研究
- 中風22 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。